Published in Cancer Weekly, July 13th, 1998
M.N. Saleh, representing colleagues from the University of Alabama and Glaxo Wellcome, Inc., discussed trial results at the 34th Annual Meeting of the American Society of Clinical Oncology, held May 16-19, 1998, in Los Angeles, California (abstract "Phase I Trial Testing Multiple Doses of Humanized Monoclonal Antibody 3622W94").
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.